HRSA Sends Previously Audited 340B Hospital a Second Follow-up Compliance Letter

HRSA headquarters
A HRSA manufacturer audit found that drugmakers Cencora and Medefil Inc. owe repayments to 340B providers.
A hospital that the U.S. Health Resources and Services Administration audited for 340B program compliance and then was one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Recertification for Hospitals Starts Aug. 14

HRSA hospital recertification.
HRSA announced this year's 340B eligibility recertification period for hospitals will start Aug. 14 and end Sept. 11.
This year’s 340B eligibility recertification period for hospitals will start Aug. 14 and end Sept. 11, the U.S. Health Resources [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amgen, Vertex, and AstraZeneca Post 340B Refund and Replenishment Public Notices

Aranesp
Aranesp is among the drugs listed on HRSA's latest manufacturer's notice posted on behalf of Amgen.
The U.S. Health Resources and Services Administration (HRSA) this week published notices from drug makers Amgen and Vertex about refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Report Publisher and CEO to Providers: New 340B Reporting Requirements are Inevitable

Tim Walz
Minnesota became the first state to impose 340B reporting requirements after Gov. Tim Walz (D) signed legislation in late May.
Health care providers almost certainly will have to accept new 340B reporting requirements in order to get unfettered access to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Large Drug Maker, Big Health System, and Influential Health Center Jointly Lobbying for Senate Bipartisan 340B Initiative

340B Working Table 340B lobbying disclosure form
Under the name 340B Working Table, Genentech, Sanford Health, and Carolina Health Centers are jointly lobbying for a bipartisan U.S. Senate 340B reform initiative.

Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations

Read More »

NACHC Names Prominent Physician with Health Center and HRSA Experience as its Leader

Dr. Kyu Rhee
NACHC has chosen Dr. Kyu Rhee, now CVS Health senior vice president and Aetna chief medical officer, to be its new president and CEO.
The National Association of Community Health Centers (NACHC) announced yesterday that its board has chosen Dr. Kyu Rhee, now CVS [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. House Energy & Commerce Committee Drafting Drug Shortages Bill

Cathy McMorris Rodgers
U.S. House Energy & Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) says the panel plans to circulate a draft drug shortage bill in the coming weeks.
The U.S. House Energy & Commerce Committee plans to circulate a draft drug shortage bill in the coming weeks, committee [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Commentary in NEJM Backs Making Hospitals Report Gross Profits from 340B

NEJM
To encourage nonprofit hospitals to do more for their communities, policymakers could examine how hospitals are using their gross profit from the 340B program, an opinion article in The New England Journal of Medicine says.
The 340B drug pricing program has evolved from a “buy low, sell low” program to help safety-net hospitals serve low-income [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer